4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-22-025847
10% owner sold 60,609 shares at an average $20.70 ($1,254,642)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ALS Invest 1 B.V. 10% owner | 2022-07-06 | Sale | −18,312 | $19.54 | $357,816 | 5,937,577 | D |
| ALS Invest 1 B.V. 10% owner | 2022-07-06 | Sale | −10,395 | $20.60 | $214,137 | 5,927,182 | D |
| ALS Invest 1 B.V. 10% owner | 2022-07-06 | Sale | −29,595 | $21.32 | $630,965 | 5,897,587 | D |
| ALS Invest 1 B.V. 10% owner | 2022-07-06 | Sale | −2,307 | $22.42 | $51,723 | 5,895,280 | D |
| Open-market sales · 60,609 sh · avg $20.70 · $1,254,642 | |||||||
Loading xslF345X03/doc4.xml…